SF1126 for Patients With Relapsed or Refractory Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven DuBois, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Children Hospital of Colorado
Aurora, Colorado, United States
- Aflac Cancer Center and Blood Disorders Service of Children'S Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, United States
- University of Chicago Comer Children'S Hospital
Chicago, Illinois, United States
- Childrens Hospital Boston, Dana-Farber Cancer Institute.
Boston, Massachusetts, United States
- C.S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Cook Children'S Healthcare System
Fort Worth, Texas, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2015
- Primary completion
- 22 May 2018
- Completion
- 22 May 2018
- Last update posted
- 20 Aug 2018
- Registered enrollment
- 4
- Registry id
- NCT02337309
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.